Condition
Cetuximab N01 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Cetuximab N01 clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Neoadjuvant therapy with encorafenib plus cetuximab N01 and mFOLFOX6 in locally advanced BRAF V600E-mutant colorectal cancer
This trial tests a targeted, pre-surgery treatment to see if it improves the chance of long-term control in adults with locally advanced BRAF V600E-mutant colorectal cancer.
-
Neoadjuvant fulzerasib plus cetuximab N01 for KRAS G12C–mutated locally advanced colorectal cancer
This trial will try a chemo-free combination of fulzerasib and cetuximab N01 before surgery in adults with KRAS G12C–mutated locally advanced colorectal cancer, including some with resectable metastases.
Related topics
Quick answers
How many Cetuximab N01 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.